$14.6M
Qualified
maximum offering price, as qualified
$0
Reported Sold
1-K 2020-09-03
10
Filings
across 3 offerings
Equity Classes
| Type | Class | Outstanding |
|---|---|---|
| common | Common Stock | 12,917,838 |
Service Providers
| Role | Provider | Fees |
|---|---|---|
| auditor | Ankit | $20K |
| legal | Pearson Butler | $10K |
| sales commission | Dalmore Group LLC | $208K |
Offerings
| File Number | Filings | First Filed | Last Filed | Qualified | Commenced | Price/Security | Securities Offered | Securities Sold | Qualified Sold | Outstanding | Aggregate Offering | Proceeds Reported | Issuer Portion | Selling Holders | Prior 12mo Qualified | Concurrent Offering | Estimated Net | CRD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 024-11314 | 4 | 2020-09-08 | 2020-11-24 | 2020-11-25 | — | $2.00 | 4,543,788 | — | — | 12,917,838 | $9.1M | — | $7M | $2.1M | $0 | $0 | $6.4M | 136352 |
| 024-10909 | 4 | 2018-10-15 | 2020-09-03 | 2018-12-19 | 2018-12-19 | $3.00 | 1,832,533 | 0 | 1,832,533 | 11,551,200 | $5.5M | $0 | $4M | $1.5M | $0 | $0 | $0 | — |
The statements and reported figures behind Global Cancer Technology, Inc.
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
Part of the Alts plan — $40/mo at launch pricing ($100 list)
External link: SEC Filings